Literature DB >> 308962

Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses.

J J Farrar, P L Simon, W J Koopman, J Fuller-Bonar.   

Abstract

Supernatants from concanavalin A-induced mouse spleen cells contain soluble factors which: 1) augment the anti-sheep erythrocyte hemolytic plaque-forming cell response of nude mouse spleen cells, 2) facilitate the generation of antigen-specific cytotoxic cells by alloantigen-stimulated thymocytes, and 3) enhance the mitogenic response of thymocytes in the presence or absence of phytohemagglutinin. The uninduced control spleen cell supernatants contained variable but significantly less biologic activity within the difference assay systems. The principle enhancing activity (apparent m.w. 35,000 to 38,000) in each of the assay systems was found to be inseparable after a multiple step purification scheme involving ammonium sulfate precipitation, two-cycle gel filtration, hydroxylapatite chromatography, and hydrophobic chromatography on Phenyl Sepharose. These results indicate that either a single factor (designated thymocyte mitogenic factor) augments both humoral and cell-mediated immune responses or, alternatively, the different biologic activities are mediated by different factors that share a common core structure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  An adhesive glycoprotein from rat ascites hepatoma cells potentiates natural cytotoxic activity by rat spleen cells.

Authors:  J Y Chen; R Kurano; M Hirashima; H Hayashi
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Concanavalin A stimulation of mouse lymphocytes at low concentration. II. The effect of conditioned medium from peritoneal exudate cells and from lymphocyte cultures.

Authors:  B Young
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

3.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

4.  Detection and characterization of a lymphocyte proliferating factor (LPF) in plasma of SJL/J mice infected with the LDH virus.

Authors:  C G Crispens
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts.

Authors:  S B Mizel; J E DeLarco; G J Todaro; W L Farrar; M L Hilfiker
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Purification and initial characterization of rat interleukin 2.

Authors:  G Di Sabato
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.

Authors:  Y Kikuchi; T Kita; K Oomori; M Miyauchi; I Iwano; I Kizawa
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

9.  Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.

Authors:  A S Stern; Y C Pan; D L Urdal; D Y Mochizuki; S DeChiara; R Blacher; J Wideman; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes.

Authors:  M Spitz; A Gearing; M Callus; L Spitz; R Thorpe
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.